TY  - BOOK
AU  - Fatih Özdener
PY  - 2022
CY  - Berlin, Germany
PB  - Peter Lang Verlag
SN  - 9783631863855
TI  - Clinical Research at MENA
T2  - Challenges and Solutions
DO  - 10.3726/b18862
UR  - https://www.peterlang.com/document/1140551
N2  - The meaning of Clinical Trials for humans has recently changed significantly, “evolved”, so to speak. In today’s environment, where ethical validity is much more strictly controlled, this meaning is far beyond “human drug testing” and much closer to the “therapeutic goal”. The number of clinical trials in western countries that have perceived this change has increased rapidly and continues to increase. Although the number of clinical studies in the MENA region is increasing day by day, it is still far from its potential. Among the reasons for this are legal, technological, ethical, epidemiological, educational and economic factors. This book presents both the difficulties encountered in conducting clinical trials in MENA and suggestions for solving these difficulties.
KW  - Sponsoring CTs at  MENA-Need of new pharmacoeconomic models, The Requirement and Importance of Legal Regulations in Drug Clinical Trials, Clinical Trial Designs of the future-Getting ready at MENA, Clinical Research and Healthcare Digitalization in the Middle East and Turkey, Early phase CTs-Importance of entry to MENA, Ethical considerations, General Picture of Clinical Research at MENA, Importance of Epidemiological Data, Improving awareness through training for CTs, Role of Regulatory Authority, Role of Investigator
LA  - English
ER  -